Diagnosis and therapy of ulcerative colitis: Results of an evidence based consensus conference by the German society of digestive and metabolic diseases and the competence network on inflammatory bowel disease;Diagnostik und therapie der colitis ulcerosa: Ergebnisse einer evidenzbasierten konsensuskonferenz der Deutschen gesellschaft für verdauungs- und stoffwechselerkrankungen zusammen mit dem kompetenznetz chronisch entzündliche darmerkrankungen

Zeitschrift fur Gastroenterologie

Volumn 42, Issue 9, 2004, Pages 979-983

  Hoffmann, J C ^a   Zeitz, M ^a   Bischoff, S C ^a   Brambs, H J ^a   Bruch, H P ^a   Buhr, H J ^a   Dignass A ^a   Fischer, I ^a   Fleig, W ^a   Folsch U R ^a   Herrlinger, K ^a   Hohne W ^a   Jantschek, G ^a   Kaltz, B ^a   Keller, K M ^a   Knebel, U ^a   Kroesen, A J ^a   Kruis, W ^a   Matthes, H ^a   Moser, G ^a   Mundt, S ^a   Pox, C ^a   Reinshagen, M ^a   Reissmann A ^a   Riemann, J ^a   Rogler, G ^a   Schmiegel, W ^a   Scholmerich J ^a   Schreiber, S ^a   Schwandner, O ^a   Selbmann, H K ^a   Stange, E F ^a   Utzig, M ^a   Wittekind, C ^a   more..

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; BALSALAZIDE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; OLSALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; TACROLIMUS;

COMPETENCE; CONFERENCE PAPER; CONSENSUS; ENTERITIS; EVIDENCE BASED MEDICINE; GERMANY; HUMAN; MEDICAL SOCIETY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; CHILD; COLITIS, ULCERATIVE; COSTS AND COST ANALYSIS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; PREGNANCY; RECURRENCE; REMISSION INDUCTION; RISK FACTORS;

EID: 7044243293     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-813510     Document Type: Conference Paper

References (21)

1. Timmer A. Epidemiologie der CED. In: Hoffmann JC, Kroesen AJ, Klump B (Hrsg). Chronisch entzündliche Darmerkrankungen: Das CED-Handbuch für Klinik und Praxis. 1. Auflage. Stuttgart, New York: Thieme, 2004: 8-19
2. Shivananda S, Lennard-Jones J, Logan R et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39: 690-697
3. Rosch M, Leidl R, Tirpitz C et al. [Cost measurement based on a cost diary in patients with inflammatory bowel disease]. Z Gastroenterol 2002; 40: 217-228
4. Ebinger M, Leidl R, Thomas S et al. Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital. J Gastroenterol Hepatol 2004; 19: 192-199
5. Stange EF, Riemann J, von Herbay A et al. Diagnostik und Therapie der Colitis ulcerosa: Ergebnisse einer evidenzbasierten Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselerkrankungen. Z Gastroenterol 2001; 39: 19-20
6. Lowry PW, Franklin CL, Weaver AL et al. Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide. Gut 2001; 49: 656-664
7. Rajwal SR, Puntis JW, McClean P et al. Endoscopic rectal sparing in children with untreated ulcerative colitis. J Pediatr Gastroenterol Nutr 2004; 38: 66-69
8. Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 2003; 88: 995-1000
9. Kugathasan S, Judd RH, Hoffmann RG et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr 2003;143:525-531
10. Gremse DA, Crissinger KD. Ulcerative colitis in children: medical management. Paediatr Drugs 2002; 4: 807-815
11. Keller KM. CED Betreuung von Kindern. In: Hoffmann JC, Kroesen AJ, Klump B (Hrsg). Chronisch entzündliche Darmerkrankungen: Das CED Manual für Klinik und Praxis. 1st edn. Stuttgart, New York: Thieme, 2004: 205-224
12. Korelitz BI. Inflammatory bowel disease and pregnancy. Gastroenterol Clin North Am 1998; 27: 213-224
13. Olsen KO, Joelsson M, Laurberg S et al. Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis. Br J Surg 1999; 86: 493-495
14. Norgard B, Puho E, Pedersen L et al. Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study. Am J Gastroenterol 2003; 98: 2006-2010
15. Willoughby CP, Truelove SC. Ulcerative colitis and pregnancy. Gut 1980; 21: 469-474
16. Nielsen OH, Andreasson B, Bondesen S et al. Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983; 18: 735-742
17. Rajapakse RO, Korelitz BI, Zlatanic J et al. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol 2000; 95: 684-688
18. Francella A, Dyan A, Bodian C et al. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 2003; 124: 9-17
19. Lobel EZ, Korelitz BI, Xuereb MA et al. A search for the optimal duration of treatment with 6-mercaptopurine for ulcerative colitis. Am J Gastroenterol 2004; 99: 462-465
20. Gurudu S, Fiocchi C, Katz JA. Inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2002; 16: 77-90
21. Das Leitlinien Manual. Entwicklung und Implementierung von Leitlinien in der Medizin. Z Arztl Fortbild Qualitatssich 2001; 95 (Suppl 1): 1-84